News & Events
May 6, 2020
What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics PlatformJoin C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), an integrated database and analytics hub designed to be used in building novel tools to accelerate drug development across rare diseases. Wednesday, May 6 at 1 PM EDT. Register......
April 29, 2020 - May 6, 2020
CANCELLED: 2020 Pediatric Academic Societies Meeting – International Stakeholder Collaboration to Develop Neonatal Therapeutics: How to Play Well in the Global Sandbox
C-Path’s International Neonatal Consortium (INC) will host a panel discussion at the 2020 Pediatric Academic Societies Meeting in Philadelphia, Saturday, May 2, titled, “International Stakeholder Collaboration to Develop Neonatal Therapeutics: How to Play Well in the Global Sandbox.” INC convenes academic experts, regulators, nurses, industry sponsor and patient/parent advocates from across the globe to forge a predictable regulatory path for evaluating the safety and effectiveness of therapies for neonates. More information…
March 30, 2020 - March 31, 2020
POSTPONED: 2020 DIA Digital Technology in Clinical Trials ConferenceThe ePRO Consortium is pleased to be a co-sponsor of the upcoming 2020 DIA Digital Technology in Clinical Trials Conference to be held from March 30-31, 2020 in Boston, MA. This multi-track conference will bring together thought-leaders from regulatory agencies, biotech, pharmaceutical, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for......
October 29, 2019
2019 Annual Meeting and Regulatory Science WorkshopOctober 29, 2019 Crystal Gateway Marriott | Arlington, VA The key objectives of the meeting are: To discuss the proposed strategy for CPAD of developing comprehensive solutions for AD drug development, based on a quantitative understanding of disease progression across the entire AD continuum To review and define a path to advance the progress of......
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel BiomarkersTitle Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development......